HomeOpen Access NewsPharmaceutical Industry

Pharmaceutical Industry

Why the pharmaceutical industry must go green

Health Care Without Harm aims to transform global healthcare to minimize its environmental impact and promote sustainability. Lorna Rothery spoke to the team about the effects of pharmaceutical pollution and the necessity for the industry to adopt greener practices.

Cannabinoids as an alternative to opioids for chronic pain

Cannabinoids with high THC-to-CBD ratios can help to improve moderate, short-term chronic pain band may be an alternative to opioids.

Universal flu vaccine trial opens at NIH Clinical Center

A Phase 1 clinical trial of a universal flu vaccine has started inoculating healthy adult volunteers at the National Institutes of Health Clinical Center in Maryland.

Acoustic Cluster Therapy – A novel ultrasound-mediated drug delivery platform for therapeutic enhancement across multiple diseases

Optimising a drug’s ability to reach diseased body parts in adequate levels while avoiding healthy body parts – its tissue exposure and selectivity – is critical to therapeutic optimisation.

The importance of personalised medicine & technology in the future of medical cannabis

Dr Stephen Barnhill M.D from Apollon Formularies Plc discusses the potential for technology to upgrade personalised medicine for cannabis treatments.

UK Cannabis Industry – the next Scottish Whisky

Nick Morland, Tenacious Labs CEO, All-Party Parliamentary Group for CBD Products Secretariat, Jersey Cannabis Services Advisory Board Chair, writes about the UK Cannabis Industry – could this be the next Scottish Whisky?

Do labels efficiently tell you what’s in your weed strain?

Research finds that labels on weed often fail to adequately reflect products' chemical make-up and components of the weed strain.

Study explores cheaper way to produce compounds for pharmaceuticals

Researchers have developed a new tool that can make it easier and cheaper to fabricate the compounds needed for pharmaceuticals.

Ukrainian patients lose access to multiple sclerosis drug trial

Biotechnology giant Roche warns that multiple sclerosis (MS) drug trials are compromised in Ukraine - with patients losing access to crucial treatment.

Are animal CBD products safe?

Suzette Smiley-Jewell, PhD & Pamela J. Lein, PhD from the University of California, Davis, explore the extent to which animal CBD products are safe

Combining AI tech with drug development efforts

Can Artificial Intelligence (AI) change the process of drug development for the pharmaceutical industry?

Medical cannabis-based treatments: Research, production & distribution

Prof Trevor M Jones charts the priorities for research and development, production and distribution of medical cannabis-based treatments

The UK’s doomed Medical Cannabis (Access) Bill

Senior Associate, David Hardstaff and Partner, John Binns of BCL Solicitors LLP, explore the UK’s doomed Medical Cannabis (Access) Bill

Antimicrobial resistance now kills more people than HIV or malaria

According to a new study in The Lancet, antimicrobial resistance is now a leading cause of death worldwide, higher than HIV/AIDS or malaria.

New Pfizer Covid-19 pill seeking emergency use authorization from FDA

Pfizer have announced that it is seeking emergency use authorization for its new Covid-19 oral antiviral candidate PAXLOVID™

How to compete with COVID-19 with a computer?

Y-h. Taguchi, Professor at Chuo University in Japan, reveals how to compete with COVID-19 by using a computer.

Pfizer COVID-19 pill 89% effective against death

Pfizer has announced that its antiviral pill, PAXLOVID, is 89% effective in reducing COVID-19 hospitalisation and death.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders